These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 37190

  • 1. Effect of acebutolol on dynamic ischemic ECG changes: a study using ambulatory twenty-four-hour ECG monitoring.
    Admon D, Kamchi A, Lewis BS, Gotsman MS.
    Isr J Med Sci; 1979 Mar; 15(3):207-11. PubMed ID: 37190
    [Abstract] [Full Text] [Related]

  • 2. Acebutolol in angina pectoris: objective assessment using graded treadmill testing.
    Kimchi A, Gotsman MS, Lewis BS.
    Isr J Med Sci; 1978 Sep; 14(9):941-7. PubMed ID: 363642
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Acute effects of oral acebutolol on exercise tolerance in patients with stable angina pectoris (author's transl)].
    Scrutinio D, De Toma L, Mangini S, Boscia F, Quagliara D, De Nicolò M, Rizzon P.
    G Ital Cardiol; 1981 Sep; 11(3):364-72. PubMed ID: 7026336
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Comparison of the effect of a selective and a nonselective beta receptor blocker on the ischemic ST segment, lung function and stress-induced decrease in blood glucose].
    Brügmann U, Blasini R.
    Herz; 1986 Feb; 11(1):55-61. PubMed ID: 2870014
    [Abstract] [Full Text] [Related]

  • 9. Slow-release metoprolol in angina pectoris. A comparative study of a cardioselective beta-blocking drug, metoprolol, in ordinary and slow-release tablets (Durules) in the treatment of angina pectoris.
    Uusitalo AJ, Keyriläinen O.
    Ann Clin Res; 1979 Oct; 11(5):199-204. PubMed ID: 44671
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of nifedipine, acebutolol, and their association on exercise tolerance in patients with effort angina.
    De Ponti C, De Biase AM, Pirelli S, Cataldo G, Salvadé P, Lanocita M, Carù B.
    Cardiology; 1981 Oct; 68 Suppl 2():195-9. PubMed ID: 7032697
    [Abstract] [Full Text] [Related]

  • 14. Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem.
    Cocco G, Rousseau MF, Bouvy T, Cheron P, Williams G, Detry JM, Pouleur H.
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):131-8. PubMed ID: 1383622
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Duration of the effect and dose-response relationship of ridazolol in patients with coronary heart disease].
    Fach WA, Starke E, Becker HJ.
    Z Kardiol; 1992 Jun; 81(6):320-5. PubMed ID: 1353933
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pulmonary effects of acebutolol, a "cardioselective" beta adrenergic blocking agent.
    DiBianco R, Dickie KJ, Singh S, Katz RJ, Costello RB, Gottdiene JS, Laddu AR, Fletcher RD.
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):1-7. PubMed ID: 6120142
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.